Philippine Standard time

Preparing for shortages of future Covid-19 drugs: A data-based model for optimal allocation.

DLSU-AKI Policy Brief, Volume XIII, No. 1.
2020

Future approved COVID-19 drugs will be short in supply until global production capacity is built up to meet demand. It is necessary for health administrators to exercise sound judgement in allocating a very scarce resource.

Citations

This publication has been cited time(s).

Contributor
DLSU - Angelo King Institute for Economic and Business Studies
Authors
Torneo, Ador, R.
Keywords
Cite
Downloads

47

Since
Jul 24, 2020

More Publications from DLSU - Angelo King Institute for Economic and Business Studies
An ASEAN digital single market: Boosting the aspiration for a single market in the digital era.
2019
845 DOWNLOADS
Determinants of Entrepreneurial Venture Growth in the Philippines Using the Global Entrepreneurship Monitor
2021
833 DOWNLOADS
The Relationship between Stock Return Volatility and Trading Volume: The Case of the Philippines
2008
502 DOWNLOADS
Assessing the Potential Impacts of Reducing Philippine Corporate Income Tax and Reforming Sectoral Incentives on Poverty and Employment
2020
469 DOWNLOADS
General Asymmetric Stochastic Volatility Models Using Range Data: Estimation and Empirical Evidence from Emerging Equity Markets
2010
427 DOWNLOADS
View More Publications